Morning Buzz: ImmunoGen (IMGN), Cerus Corporation (CERS), BlackBerry (BBRY, Orexigen Therapeutics (OREX), Agenus Inc. (AGEN)

Shares ImmunoGen, Inc. (IMGN) are down over 49% in premarket trading Friday after the company reported results of its Phase III Marianne study, a breast cancer treatment from drug development partner Roche, failed to deliver significant improvement in a key late-stage study measurement of cancer patients. Roche however, has reported the Marianne study showed the […] View the full post at: Morning Buzz: ImmunoGen (IMGN), Cerus Corporation (CERS), BlackBerry (BBRY, Orexigen Therapeutics (OREX), Agenus Inc. (AGEN) No related posts.